Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients

The purpose of this study is to determine the:

* Natural history of calcification posttransplantation * Natural history of BMC following renal transplantation * Reverse correlation between calcification score and aortic calcifications following renal transplantation * Correlation of IMT, BMC, PWV and biochemical variables * Correlation of IMT, BMC, PWV, biochemical variables and outcome * Predictors of CV disease after transplantation * Predictors of IMT progression, BMC loss and PWV progression after renal transplantation

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Renal Transplant Arterial Occlusive Diseases Arterial Stiffness Arteriosclerosis Atherosclerosis Calcinosis Calcium Metabolism Disorders Cardiovascular Diseases Metabolic Diseases Nutritional and Metabolic Diseases Vascular Diseases

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

UZ Gasthuisberg

Leuven, 3000, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Incident renal transplant patients or combined renal/pancreas transplant patients

Treatment and study plan

No intervention

Other

no intervention

Primary outcomes

cardiovascular outcome

Time frame: 5 years

Sponsors and collaborators

Lead sponsor

Universitaire Ziekenhuizen KU Leuven

Other

Registry information

Acronym: ASCIT

Important dates

Study start: 2006
Primary completion: 2013
Study completion: 2013
First posted: Oct 19, 2007
Registry last updated: Oct 16, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed